Hervé Hoppenot
2014
In 2014, Hervé Hoppenot earned a total compensation of $32.7M as President and Chief Executive Officer at Incyte.
Compensation breakdown
| Bonus | $2,200,000 |
|---|---|
| Non-Equity Incentive Plan | $1,150,000 |
| Option Awards | $3,374,978 |
| Salary | $738,462 |
| Stock Awards | $24,768,977 |
| Other | $458,609 |
| Total | $32,691,026 |
Hoppenot received $24.8M in stock awards, accounting for 76% of the total pay in 2014.
Hoppenot also received $2.2M in bonus, $1.2M in non-equity incentive plan, $3.4M in option awards, $738.5K in salary and $458.6K in other compensation.
Rankings
In 2014, Hervé Hoppenot's compensation ranked 41st out of 13,032 executives tracked by ExecPay. In other words, Hoppenot earned more than 99.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 41 out of 13,032 | 100th |
Division Services | 14 out of 2,086 | 99th |
Major group Engineering, Accounting, Research, Management, And Related Services | 1 out of 191 | 100th |
Industry group Research, Development, And Testing Services | 1 out of 57 | 98th |
Industry Commercial Physical and Biological Research | 1 out of 47 | 98th |
Source: SEC filing on April 17, 2017.
Hoppenot's colleagues
We found seven more compensation records of executives who worked with Hervé Hoppenot at Incyte in 2014.
2014
David Gryska
Incyte
Chief Financial Officer
2014
Reid Huber
Incyte
Chief Scientific Officer
2014
James Daly
Incyte
Executive Vice President and Chief Commercial Officer
2014
Richard Levy
Incyte
Executive Vice President and Chief Drug Development Officer
2014
David Hastings
Incyte
Chief Financial Officer
2014
Wenqing Yao
Incyte
Executive Vice President, Head of Discovery Chemistry
2014
Paul Friedman
Incyte